N/A
N=47,396
Aligning Patient Preferences: a Role Offering Alzheimer's Patients, Caregivers, and Healthcare Providers Education and Support
Alzheimer Disease · Dementia
Bottom Line
View on ClinicalTrials.gov: NCT03323502 ↗Enrolled (actual)
47,396
Serious AEs
0.0%
Results posted
Aug 2025
Primary outcome: Primary: Hospital Transfers — 1.2; 1.3 number of hospital transfers — p=0.3313
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- APPROACHES ACP Specialist Program (Behavioral); Standard of care (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Indiana University
- Primary completion
- Aug 2022
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Hospital Transfers |
1.2; 1.3 | 0.3313 |
| SECONDARY Hospice Enrollment |
1095; 1181 | 0.3327 |
| SECONDARY Death in Hospital |
163; 146 | 0.3946 |
Summary
Nursing home (NH) patients with Alzheimer's disease and related dementias often receive unwanted, burdensome treatments such as hospitalization. Advance care planning (ACP) is a key strategy to support patients and family-caregivers in making informed decisions and ensuring treatment preferences are proactively known and honored. The ACP Specialist Program will improve care and reduce unwanted, burdensome hospitalizations through improved ACP procedures, standardized staff education on ACP, and systematic ACP facilitation delivered by existing NH staff.
Eligibility Criteria
Inclusion Criteria
- Facilities are owned by NH corporate partners
- Facilities are Medicare/Medicaid-certified
- Facilities have an electronic medical records system
- Minimum bedsize of 50 or more;
- At least 50% long-stay as defined by a length of stay of 100 days or longer.
Exclusion Criteria
- Problematic or unstable facilities will be removed in consultation with NH corporate leaders prior to randomization
Data sourced from ClinicalTrials.gov (NCT03323502). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.